FDA Adverse Event Malfunction Summary report: N

ALARIS SYSTEM

MDR report key: 23241615 · Received October 8, 2025

Report

Report Number
2016493-2025-120424
Event Type
Malfunction
Date Received
October 8, 2025
Date of Event
September 3, 2025
Report Date
November 19, 2025
Manufacturer
CAREFUSION SD
Product Code
FRN
PMA / PMN Number
K211218
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
BIOMEDICAL ENGINEER
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BD TECHNICAL SUPPORT TROUBLESHOOT WITH CUSTOMER OVER THE PHONE. A FOLLOW UP REPORT WILL BE SUBMITTED ONCE THE FAILURE INVESTIGATION HAS BEEN COMPLETED. PER 803.52(F)(11)(III) THE INFORMATION PROVIDED REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. THE COMPLAINANT OR REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO THE MANUFACTURER.

Additional Manufacturer Narrative · 0

CORRECTION: IT WAS DETERMINED THROUGH INVESTIGATION OF THE RETURNED DEVICES THAT THE INITIALLY REPORTED SUSPECT DEVICE REPORTED UNDER MANUFACTURER REPORT NUMBER 2016493-2025-120424 IS A CONCOMITANT. PLEASE REFER TO MANUFACTURER REPORT NUMBER 2016493-2025-120423, 2016493-2025-120428 WHICH CAPTURED THE CORRECT SUSPECT DEVICE PER INVESTIGATION REPORT."

Description of Event or Problem · 0

IT WAS REPORTED WHILE INFUSING EPINEPHRINE THE LVP MODULE (CHANNEL D) "TURNED ON BY ITSELF AND STARTED TO INFUSE EPINEPHRINE AT A RATE OF 75ML/HR." PER REPORT, THE DEVICE WAS TURNED OFF AGAIN AND ABOUT A HALF HOUR LATER IT TURNED ON AGAIN. ONE PCU AND 4 LVPS WERE INVOLVED AT THE TIME OF THE EVENT. LINES AND MEDICATIONS WERE VERIFIED TO BE CORRECT. THE PATIENT EXPERIENCED A HEART RATE INCREASE, BUT NO HARM. ADDITIONAL INFORMATION PROVIDED: THE CUSTOMER STATES "WHAT WE WERE ABLE TO IDENTIFY: THE PUMP WAS SOMEHOW LINKED TO A PATENT AT ANOTHER (FACILITY B) USING THE SAME ALARIS FORMULARY SERVER, EPIC SERVER, AND WIRELESS NETWORK SSID SO A PUMP FROM ANY OF OUR HOSPITAL CAN GET ON THE NETWORK AT ANY FACILITY SITE. WE DO NOT USE THE PATIENT OPERABILITY FEATURE AT FACILITY A, BUT THEY DO AT FACILITY B. WHAT WE SUSPECT IS THAT THE PUMP WAS ON A PATIENT AT FACILITY B AND THEN THE PUMP WAS RETURNED TO FACILITY A WHERE IT WAS USED ON AN OPERATING ROOM CASE ON (B)(6) 2025, AND WHEN PROGRAMMED FOR THIS NEW PATIENT "NO" WAS ENTERED WHICH LEFT THE PREVIOUS PATIENT STILL ENTERED IN THE PUMP. IN OUR EPIC SYSTEM IT SHOWS DATA GOING INTO EPIC FOR A PATIENT AT FACILITY B AND THAT THE PUMP WAS AT FACILITY B ON (B)(6) 2025. BOTH DAYS IT WAS AT FACILITY A.

Description of Event or Problem · 0

IT WAS REPORTED WHILE INFUSING EPINEPHRINE THE LVP MODULE (CHANNEL D) "TURNED ON BY ITSELF AND STARTED TO INFUSE EPINEPHRINE AT A RATE OF 75ML/HR." PER REPORT, THE DEVICE WAS TURNED OFF AGAIN AND ABOUT A HALF HOUR LATER IT TURNED ON AGAIN. ONE PCU AND 4 LVPS WERE INVOLVED AT THE TIME OF THE EVENT. LINES AND MEDICATIONS WERE VERIFIED TO BE CORRECT. THE PATIENT EXPERIENCED A HEART RATE INCREASE, BUT NO HARM. ADDITIONAL INFORMATION PROVIDED: THE CUSTOMER STATES "WHAT WE WERE ABLE TO IDENTIFY: THE PUMP WAS SOMEHOW LINKED TO A PATENT AT ANOTHER (FACILITY B) USING THE SAME ALARIS FORMULARY SERVER, EPIC SERVER, AND WIRELESS NETWORK SSID SO A PUMP FROM ANY OF OUR HOSPITAL CAN GET ON THE NETWORK AT ANY FACILITY SITE. WE DO NOT USE THE PATIENT OPERABILITY FEATURE AT FACILITY A, BUT THEY DO AT FACILITY B. WHAT WE SUSPECT IS THAT THE PUMP WAS ON A PATIENT AT FACILITY B AND THEN THE PUMP WAS RETURNED TO FACILITY A WHERE IT WAS USED ON AN OPERATING ROOM CASE ON SEPTEMBER 3, 2025, AND WHEN PROGRAMMED FOR THIS NEW PATIENT "NO" WAS ENTERED WHICH LEFT THE PREVIOUS PATIENT STILL ENTERED IN THE PUMP. IN OUR EPIC SYSTEM IT SHOWS DATA GOING INTO EPIC FOR A PATIENT AT FACILITY B AND THAT THE PUMP WAS AT FACILITY B ON SEPTEMBER 3, 2025, AND SEPTEMBER 4, 2025. BOTH DAYS IT WAS AT FACILITY A.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2583934 ALARIS SYSTEM PUMP, INFUSION FRN CAREFUSION SD 8100

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown